Health Care·Pharmaceuticals·$3.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.62 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.62 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management acknowledged the challenges faced in the quarter. They emphasized a commitment to their long-term strategy but did not provide specific guidance.
Management did not provide specific revenue figures or guidance for the upcoming quarters.
The company is focused on its strategic initiatives despite the current financial performance.
Liquidia Corp's earnings report showed a loss per share of $0.62, which did not meet expectations. The stock reacted negatively, dropping 5.46%. The lack of revenue figures and guidance may have contributed to investor uncertainty about the company's future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BWX TECHNOLOGIES INC
Feb 25, 2019